Ratings by Jefferies (Maury Raycroft)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/4/2024 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | Cue Biopharma | CUE | New Coverage | Buy (N/A) |
1.90 (1.56) |
-17.89% | Details | |
| 3/6/2024 | Corbus Pharmaceuticals | CRBP | Upgrade | Buy (Hold) |
34.60 (39.24) |
13.41% | Details | |
| 2/8/2024 | Tempest Therapeutics | TPST | New Coverage | Buy (N/A) |
4.19 (3.10) |
-26.01% | Details | |
| 12/26/2023 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
11.44 (23.25) |
103.23% | Details | |
| 11/3/2023 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2023 | Mirati Therapeutics | MRTX | Downgrade | Hold (Buy) |
62.38 (58.70) |
-5.9% | Details | |
| 8/4/2023 | BioCryst Pharma | BCRX | Upgrade | Buy (Hold) |
7.08 (4.43) |
-37.43% | Details | |
| 7/28/2023 | Reata Pharmaceuticals | RETA | Downgrade | Hold (Buy) |
108.55 (172.36) |
58.78% | Details | |
| 7/10/2023 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Allakos | ALLK | Upgrade | Buy (Hold) |
43.11 (2.99) |
-93.06% | Details | |
| 1/31/2023 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
3.94 (1.47) |
-62.69% | Details | |
| 1/19/2023 | Concert Pharmaceuticals | CNCE | Downgrade | Hold (Buy) |
6.90 (8.37) |
21.3% | Details | |
| 1/4/2023 | Vera Therapeutics | VERA | Downgrade | Hold (Buy) |
18.30 (38.00) |
107.65% | Details | |
| 12/6/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Imago Biosciences Inc | IMGO | Downgrade | Hold (Buy) |
17.40 (36.01) |
106.95% | Details | |
| 10/3/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2022 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Rezolute | RZLT | New Coverage | Buy (N/A) |
2.19 (3.43) |
56.62% | Details | |
| 9/2/2022 | Forma Therapeutics | FMTX | Downgrade | Hold (Buy) |
13.40 (20.01) |
49.33% | Details | |
| 8/17/2022 | Imago Biosciences Inc | IMGO | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2022 | Kezer Life Sciences | KZR | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2022 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Forma Therapeutics | FMTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2022 | Kezer Life Sciences | KZR | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | Sierra Oncology Inc | SRRA | Downgrade | Hold (Buy) |
39.52 (54.99) |
39.14% | Details | |
| 12/22/2021 | Allakos Inc. | ALLK | Downgrade | Hold (Buy) |
84.39 (1.07) |
-98.73% | Details | |
| 12/13/2021 | Imago Biosciences Inc | IMGO | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2021 | BeyondSpring Inc. | BYSI | Downgrade | Hold (Buy) |
12.77 (1.91) |
-85.04% | Details | |
| 11/30/2021 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | Ayala Pharmaceuticals | AYLA | Upgrade | Buy (Hold) |
9.48 (0.50) |
-94.73% | Details | |
| 11/8/2021 | Tyra Biosciences | TYRA | Downgrade | Hold (Buy) |
28.39 (14.98) |
-47.23% | Details | |
| 11/1/2021 | Theseus Pharmaceuticals Inc | THRX | New Coverage | Buy (N/A) |
17.12 (4.06) |
-76.29% | Details | |
| 10/11/2021 | Tyra Biosciences | TYRA | New Coverage | Buy (N/A) |
16.26 (28.39) |
74.6% | Details | |
| 9/7/2021 | Celcuity Inc | CELC | New Coverage | Buy (N/A) |
21.50 (17.24) |
-19.81% | Details | |
| 8/10/2021 | Imago Biosciences Inc | IMGO | New Coverage | Buy (N/A) |
22.99 (36.01) |
56.63% | Details | |
| 8/9/2021 | MRTI | Maintain | Buy (N/A) |
|
Details | |||
| 8/9/2021 | BioCryst Pharma | BCRX | Downgrade | Hold (Buy) |
17.65 (4.43) |
-74.9% | Details | |
| 8/6/2021 | BioCryst Pharma | BCRX | Downgrade | Hold (Buy) |
17.65 (4.43) |
-74.9% | Details | |
| 7/9/2021 | Aslan Pharma | ASLN | New Coverage | Buy (N/A) |
3.16 (0.51) |
-83.86% | Details | |
| 7/1/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2021 | Forma Therapeutics | FMTX | New Coverage | Buy (N/A) |
24.26 (20.01) |
-17.52% | Details | |
| 6/1/2021 | Valneva SE | VALN | New Coverage | Buy (N/A) |
25.98 (7.58) |
-70.82% | Details | |
| 5/27/2021 | Solid Biosciences | SLDB | New Coverage | Buy (N/A) |
3.78 (8.70) |
130.16% | Details | |
| 5/10/2021 | Mirati Therapeutics | MRTX | Upgrade | Buy (Hold) |
150.77 (58.70) |
-61.07% | Details | |
| 4/21/2021 | CRISPR Therapeutics | CRSP | Upgrade | Buy (Hold) |
121.67 (55.05) |
-54.75% | Details | |
| 3/31/2021 | Chimerix | CMRX | New Coverage | Buy (N/A) |
8.59 (0.88) |
-89.76% | Details | |
| 3/25/2021 | Kezer Life Sciences | KZR | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2021 | Checkmate Pharmaceuticals | CMPI | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2021 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 12/21/2020 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Arrowhead Pharma | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2020 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Allakos Inc. | ALLK | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2020 | CRISPR Therapeutics | CRSP | Downgrade | Hold (Buy) |
146.63 (55.05) |
-62.46% | Details | |
| 11/10/2020 | Mirati Therapeutics | MRTX | Downgrade | Hold (Buy) |
227.22 (58.70) |
-74.17% | Details | |
| 10/27/2020 | Oncorus Inc. | ONCR | New Coverage | Buy (N/A) |
16.40 (0.12) |
-99.27% | Details | |
| 10/6/2020 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | Corbus Pharmaceuticals | CRBP | Downgrade | Hold (Buy) |
9.25 (34.60) |
274.05% | Details | |
| 9/1/2020 | Checkmate Pharmaceuticals | CMPI | New Coverage | Buy (N/A) |
15.58 (10.50) |
-32.61% | Details | |
| 8/14/2020 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2020 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | LogicBio Therapeutics | LOGC | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Stealth BioTherapeutics | MITO | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2020 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Sierra Oncology Inc | SRRA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/10/2020 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2020 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Arrowhead Research | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Retrophin | RTRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Opko Health | OPK | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2020 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2020 | Fusion Pharmaceuticals | FUSN | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2020 | Constellation Pharmaceuticals | CNST | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2020 | Constellation Pharmaceuticals | CNST | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Calliditas Therapeutics | CALT | New Coverage | Buy (N/A) |
19.95 (18.70) |
-6.27% | Details | |
| 6/25/2020 | Ayala Pharmaceuticals | AYLA | Maintain | Hold (N/A) |
|
Details | ||
| 6/23/2020 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2020 | BeyondSpring Inc. | BYSI | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Ayala Pharmaceuticals | AYLA | New Coverage | Hold (N/A) |
15.70 (0.50) |
-96.82% | Details | |
| 6/2/2020 | Alithya Group Inc | ALYA | New Coverage | Hold (N/A) |
1.77 (1.13) |
-36.16% | Details | |
| 5/19/2020 | ORIC Pharamceuticals | ORIC | New Coverage | Buy (N/A) |
31.88 (9.19) |
-71.17% | Details | |
| 5/10/2020 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 5/8/2020 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2020 | Constellation Pharmaceuticals | CNST | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2020 | Stealth BioTherapeutics | MITO | Maintain | Hold (N/A) |
|
Details | ||
| 3/30/2020 | Concert Pharmaceuticals | CNCE | New Coverage | Buy (N/A) |
9.35 (8.37) |
-10.48% | Details | |
| 3/4/2020 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Black Diamond Therapeutics | BDTX | New Coverage | Buy (N/A) |
37.92 (5.26) |
-86.13% | Details | |
| 2/13/2020 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2020 | BeyondSpring Inc. | BYSI | New Coverage | Buy (N/A) |
17.20 (1.91) |
-88.9% | Details | |
| 1/29/2020 | Spring Bank Pharmaceuticals | SBPH | Downgrade | Hold (Buy) |
1.70 (1.21) |
-28.82% | Details | |
| 1/10/2020 | Aurinia Pharmaceuticals | AUPH | New Coverage | Buy (N/A) |
20.40 (4.99) |
-75.54% | Details | |
| 10/15/2019 | Stealth BioTherapeutics | MITO | Maintain | Hold (N/A) |
|
Details | ||
| 9/16/2019 | Atara Biotherapeutics | ATRA | Downgrade | Hold (Buy) |
15.58 (0.66) |
-95.76% | Details | |
| 9/9/2019 | Mirati Therapeutics | MRTX | Upgrade | Buy (Hold) |
85.77 (58.70) |
-31.56% | Details | |
| 8/23/2019 | Retrophin | RTRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2019 | CRISPR Therapeutics | CRSP | New Coverage | Buy (N/A) |
50.72 (55.05) |
8.54% | Details | |
| 7/25/2019 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2019 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
12.18 (9.74) |
-20.03% | Details | |
| 4/5/2019 | Corbus Pharmaceuticals | CRBP | New Coverage | Buy (N/A) |
7.06 (9.25) |
31.02% | Details | |
| 3/15/2019 | Spectrum Pharmaceuticals | SPPI | New Coverage | Buy (N/A) |
10.64 (1.03) |
-90.32% | Details | |
| 12/6/2018 | OncoMed Pharmaceuticals | OMED | Downgrade | Hold (Buy) |
1.11 (0.89) |
-19.82% | Details | |
| 11/21/2018 | Zai Lab | ZLAB | New Coverage | Buy (N/A) |
17.20 (177.52) |
932.09% | Details | |
| 11/13/2018 | LogicBio Therapeutics | LOGC | New Coverage | Buy (N/A) |
13.72 (2.07) |
-84.91% | Details | |
| 10/30/2018 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Buy (N/A) |
18.82 (11.57) |
-38.52% | Details | |
| 10/30/2018 | Retrophin | RTRX | New Coverage | Buy (N/A) |
24.98 (24.25) |
-2.92% | Details | |
| 10/9/2018 | Spring Bank Pharmaceuticals | SBPH | New Coverage | Buy (N/A) |
13.12 (1.70) |
-87.04% | Details | |
| 9/10/2018 | Endocyte | ECYT | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2018 | Affimed Therapeutics | AFMD | Upgrade | Buy (Hold) |
1.60 (5.15) |
221.88% | Details | |
| 8/13/2018 | Constellation Pharmaceuticals | CNST | New Coverage | Buy (N/A) |
9.85 (29.10) |
195.43% | Details | |
| 8/13/2018 | Allakos Inc. | ALLK | New Coverage | Buy (N/A) |
37.27 (1.07) |
-97.13% | Details |
